NDA 202470 describes DESONIDE, which is a drug marketed by
Alembic,
Cadila,
Cosette,
Glenmark Speclt,
Padagis Us,
Taro,
Cintex Svcs,
Fougera Pharms,
Pai Holdings Pharm,
Encube Ethicals,
Glenmark Pharms Ltd, and
Hikma, and is included in twenty NDAs. It is available from
fourteen suppliers. Additional details are available on the
DESONIDE profile page.
The generic ingredient in DESONIDE is
desonide. There are thirty-one
drug master file entries for this compound. Seventeen
suppliers are listed for this compound. Additional details are available on the
desonide profile page.